Barclays CEO to undergo cancer treatment

Barclays has announced that its chief executive, CS Venkatakrishnan, has been diagnosed with non-Hodgkin’s lymphoma and will undergo treatment for the next 12 to 16 weeks.

In a letter to staff, Venkatakrishnan wrote: “Doctors have reported that my prognosis is excellent and my condition is curable with their prescribed regimen. This should last 12-16 weeks.

He added: “During this period, the business will operate as normal and I will continue to be actively involved in its management. However, I will have to work from home during certain periods and I will not be able to travel.”

He will be treated at Memorial Sloan Kettering Cancer Center in New York.

More updates to come

Leave a Reply

Your email address will not be published. Required fields are marked *